TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3299116

Group type: EXPERIMENTAL
Intervention: Calcitriol (up to 4 micrograms/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Calcitriol
Number of subjects: 14
Study: 31388720

Group type: EXPERIMENTAL
Intervention: Amyloid-PET
Number of subjects: 71

Group type: COMPARATOR
Intervention: CSF (Aβ42, tau, and phospho-tau)
Number of subjects: 71
Study: 30374630

Group type: EXPERIMENTAL
Intervention: Intensive support for low-risk patients (18-month mortality risk ≤ 0.16)
Number of subjects: 1023

Group type: EXPERIMENTAL
Intervention: Basic support for intermediate- to high-risk patients (18-month mortality risk > 0.16)
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 1023

Group type: COMPARATOR
Intervention: Basic support
Number of subjects: 1023
Study: 28554913

Group type: EXPERIMENTAL
Intervention: Transcatheter arterial embolisation of abnormal knee neovasculature
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 58
Study: 26494450

Group type: EXPERIMENTAL
Intervention: Sapropterin (BH4, a nitric oxide synthase cofactor; 10 mg/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 22887834

Group type: EXPERIMENTAL
Intervention: 5 h per week of Nordic walking with poles for a 4-month period
Number of subjects: 213
Study: 21302035

Group type: EXPERIMENTAL
Intervention: HTUPA 10 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: HTUPA 20 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: HTUPA 30 mg
Number of subjects: 32
Study: 19586652

Group type: EXPERIMENTAL
Intervention: p,p'-DDE
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: beta-HCH
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: HCB
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: p,p'-DDT
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: OCPs levels
Number of subjects: 953

Group type: EXPERIMENTAL
Intervention: p,p'-DDE and beta-HCB
Number of subjects: 953
Study: 16483898

Group type: EXPERIMENTAL
Intervention: Healing Touch (HT)
Number of subjects: 0
Study: 15335019

Group type: EXPERIMENTAL
Intervention: Complex dietary therapy including soy isoflavones and selenium
Number of subjects: 0
Study: 10930895

Group type: EXPERIMENTAL
Intervention: Intravenous heparin for 5 days, followed by subcutaneous heparin for 5 weeks (n=8)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-dose intravenous hydrocortisone for 5 days followed by oral prednisolone 40 mg daily, reducing by 5 mg per day each week (n=12)
Number of subjects: 20
Study: 9780100

Group type: EXPERIMENTAL
Intervention: Adjunctive daunorubicin perfusion during standardized surgery
Number of subjects: 286

Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 286
Study: 7530621

Group type: COMPARATOR
Intervention: Conventional Insulin Therapy (CIT; n = 12)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Continuous Subcutaneous Insulin Infusion (CSII; n = 12)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intraportal Insulin Infusion (IPII; n = 12)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intensified insulin therapy (CSII)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intensified insulin therapy (IPII)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Diabetic patients
Number of subjects: 36
Study: 3280505

Group type: EXPERIMENTAL
Intervention: Time-limited individual psychotherapy
Number of subjects: 98

Group type: COMPARATOR
Intervention: Time-limited group psychotherapy
Number of subjects: 98
Study: 29633812

Group type: COMPARATOR
Intervention: Ropivacaine 0.2% at 8 mL/h (Control)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.4% at 4 mL/h
Number of subjects: 64
Study: 28692468

Group type: EXPERIMENTAL
Intervention: Distal pancreatectomy with intraperitoneal drainage
Number of subjects: 344

Group type: COMPARATOR
Intervention: Distal pancreatectomy without intraperitoneal drainage
Number of subjects: 344
Study: 25287553

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (10-14 sessions: 6-10 during pregnancy and 4-8 after delivery)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy
Number of subjects: 300
Study: 24295530

Group type: EXPERIMENTAL
Intervention: 8 × 30-minute training sessions using a joystick operated wheelchair simulation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control condition (no task)
Number of subjects: 28
Study: 21569570

Group type: EXPERIMENTAL
Intervention: Multi-professional and multidimensional intervention including early geriatric assessment, early family support, case manager involvement, and planning with elderly and relatives.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 100
Study: 18245904

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Glucosamine sulfate (GS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Arthroscopic debridement (AD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: GS+AD
Number of subjects: 60

Group type: COMPARATOR
Intervention: HA'
Number of subjects: 60

Group type: COMPARATOR
Intervention: GS+HA'
Number of subjects: 60
Study: 16436164

Group type: EXPERIMENTAL
Intervention: Joint teleconferenced consultations with the patient, patient's general practitioner (GP), and a hospital specialist connected via ISDN2 link and video-conferencing software.
Number of subjects: 28
Study: 12765983

Group type: EXPERIMENTAL
Intervention: Liaison cardiac troponin I assay
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-molecular-weight heparin (dalteparin) or an invasive strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: AccuTnI assay
Number of subjects: 0
Study: 14555594

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 500 microg once-daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 100 or 200 microg once-daily
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) twice-daily (100, 200, or 500 microg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 11059181

Group type: EXPERIMENTAL
Intervention: Capillary blood specimens obtained by finger prick stored on filter paper disks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Venous blood specimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serum specimens stored for 2 months
Number of subjects: 0
Study: 8636587

Group type: EXPERIMENTAL
Intervention: Captopril 12.5 mg twice daily
Number of subjects: 81

Group type: COMPARATOR
Intervention: Bendrofluazide 2.5 mg daily
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Captopril and Bendrofluazide (combined analysis of quartiles)
Number of subjects: 81
Study: 1352011

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (60 ml chlorhexidine diacetate 2 g/l)
Number of subjects: 4483

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 4483
Study: 6535067

Group type: EXPERIMENTAL
Intervention: Clobazam
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 3330126

Group type: EXPERIMENTAL
Intervention: Immuno-hormonotherapy (IMT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Hormonotherapy (HT)
Number of subjects: 43
Study: 31259585

Group type: EXPERIMENTAL
Intervention: Retirement status (Retired)
Number of subjects: 21000

Group type: COMPARATOR
Intervention: Working status (Working older adults)
Number of subjects: 21000

Group type: EXPERIMENTAL
Intervention: Time use redistribution
Number of subjects: 21000
Study: 31028503

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Critical group (MgSO4)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Critical group (Routine treatment)
Number of subjects: 0
Study: 28376726

Group type: EXPERIMENTAL
Intervention: Behavioral sleep intervention (group teaching or printed material)
Number of subjects: 455
Study: 26265641

Group type: EXPERIMENTAL
Intervention: Three intravitreal injections of bevacizumab (IVB) at monthly intervals.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Pars plana vitrectomy (PPV) with internal limiting membrane (ILM) removal.
Number of subjects: 44
Study: 23117286

Group type: EXPERIMENTAL
Intervention: Stretching program
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control
Number of subjects: 262
Study: 22117981

Group type: EXPERIMENTAL
Intervention: Prophylactic palonosetron 0.075 mg, intravenously before induction of inhalation anaesthesia
Number of subjects: 50

Group type: COMPARATOR
Intervention: TIVA using propofol (target blood concentration 2.5‐6.0 μg/ml) and remifentanil (target blood concentration 2.5‐6.0 ng/ml)
Number of subjects: 50
Study: 19497624

Group type: EXPERIMENTAL
Intervention: Oral estrogen replacement therapy (ERT)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Transdermal estrogen replacement therapy (ERT)
Number of subjects: 2
Study: 17279193

Group type: EXPERIMENTAL
Intervention: Smaller multivitamin tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multivitamin tablets with less iron content
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard multivitamin tablets (larger size, higher iron content)
Number of subjects: 0
Study: 15588135

Group type: EXPERIMENTAL
Intervention: Serum dopamine‐beta‐hydroxylase (DBH) activity in healthy subjects
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: DBH activity in Wistar rats
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Electrophysiological parameters in healthy adolescents
Number of subjects: 250
Study: 11768897

Group type: EXPERIMENTAL
Intervention: Catheter-directed intravascular thrombolysis using thrombus-dissolving enzymes (streptokinase, urokinase, tissue plasminogen activators)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preoperative thrombolysis in late and longer lasting occlusions (>14 days)
Number of subjects: 0
Study: 9228516

Group type: EXPERIMENTAL
Intervention: Patients with sepsis (n=49)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Patients who died (n=14)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Patients who recovered (n=35)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Patients with sepsis (n=43)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (n=30)
Number of subjects: 49
Study: 7969611

Group type: EXPERIMENTAL
Intervention: Intensive care treatment for more than 30 days
Number of subjects: 223
Study: 3675911

Group type: EXPERIMENTAL
Intervention: Hypromellose
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate
Number of subjects: 88

Group type: COMPARATOR
Intervention: Air
Number of subjects: 88
Study: 31612537

Group type: EXPERIMENTAL
Intervention: Betanodavirus (one RGNNV genotype and two BFNNV genotypes)
Number of subjects: 0
Study: 28860166

Group type: EXPERIMENTAL
Intervention: Ibuprofen (600 mg ×3/day)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 25769195

Group type: EXPERIMENTAL
Intervention: Monitored aerobic exercise (40 minutes, 2 days/week, 3 months)
Number of subjects: 100
Study: 24030249

Group type: EXPERIMENTAL
Intervention: Parent Report of Children's Abilities-Revised (PARCA-R)
Number of subjects: 204
Study: 20621454

Group type: EXPERIMENTAL
Intervention: Oral olanzapine supplementation
Number of subjects: 931

Group type: COMPARATOR
Intervention: Olanzapine long-acting injection (olanzapine-LAI)
Number of subjects: 931
Study: 18652271

Group type: EXPERIMENTAL
Intervention: XP BOND‐Dual Cure/Calibra resin cement with Self‐cure and Self‐cure (SC&SC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: XP BOND‐Dual Cure/Calibra resin cement with Self‐cure and Dual‐cure (SC&DC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: XP BOND‐Dual Cure/Calibra resin cement with Dual‐cure and Dual‐cure (DC&DC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: XP BOND‐Dual Cure/FluoroCore 2 with Self‐cure and Self‐cure (SC&SC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: XP BOND‐Dual Cure/FluoroCore 2 with Self‐cure and Dual‐cure (SC&DC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: XP BOND‐Dual Cure/FluoroCore 2 with Dual‐cure and Dual‐cure (DC&DC)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Coronal region
Number of subjects: 42
Study: 16774958

Group type: EXPERIMENTAL
Intervention: Verteporfin enhanced feeder vessel therapy with varying light doses (50 J/cm2, 100 J/cm2, 125 J/cm2, 150 J/cm2)
Number of subjects: 9
Study: 12932084

Group type: EXPERIMENTAL
Intervention: Continuous bright light (> 3000 lux)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Intermittent bright light (> 3000 lux, 0.5 h on, 0.5 h off)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Ordinary dim indoor light (< 60 lux)
Number of subjects: 28
Study: 10886051

Group type: EXPERIMENTAL
Intervention: Fedotozine (30 mg, t.d.s.)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 9250101

Group type: EXPERIMENTAL
Intervention: Nutritional supplementation
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Stimulation
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control
Number of subjects: 127
Study: 7508322

Group type: EXPERIMENTAL
Intervention: Panretinal photocoagulation
Number of subjects: 725

Group type: EXPERIMENTAL
Intervention: Grid pattern photocoagulation
Number of subjects: 725

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 725

Group type: COMPARATOR
Intervention: Natural history groups
Number of subjects: 725
Study: 3707799

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine plain
Number of subjects: 50

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 50
Study: 30001944

Group type: EXPERIMENTAL
Intervention: 900 μg of salbutamol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: VSD group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 28557652

Group type: EXPERIMENTAL
Intervention: Letrozole (LE)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Clomiphene Citrate (CC)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Clomiphene Citrate (CC) + Metformin (MET)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Letrozole (LE) + Metformin (MET)
Number of subjects: 240
Study: 26013112

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - 'moving words' concept (1 English lesson relocated to sports hall for 1 year)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control Group (CG) - regular physical education (3 hours per week)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - English marks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control Group (CG) - sports marks
Number of subjects: 39
Study: 23893190

Group type: EXPERIMENTAL
Intervention: Sublingual specific immunotherapy (SLIT) for three years
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (never treated with specific immunotherapy, only symptomatic drugs)
Number of subjects: 140
Study: 21866715

Group type: EXPERIMENTAL
Intervention: Music video exposure
Number of subjects: 51

Group type: COMPARATOR
Intervention: Audio-only exposure
Number of subjects: 51
Study: 18371963

Group type: EXPERIMENTAL
Intervention: Endometrin 100 mg twice daily
Number of subjects: 1211

Group type: EXPERIMENTAL
Intervention: Endometrin 100 mg three times daily
Number of subjects: 1211

Group type: COMPARATOR
Intervention: P(4) 90 mg 8% gel daily
Number of subjects: 1211
Study: 17079850

Group type: EXPERIMENTAL
Intervention: Bisphosphonates (etidoronate, alendronate, risedronate)
Number of subjects: 0
Study: 15533587

Group type: EXPERIMENTAL
Intervention: IDet + IAsp
Number of subjects: 395

Group type: COMPARATOR
Intervention: NPH + HSI
Number of subjects: 395
Study: 11151744

Group type: EXPERIMENTAL
Intervention: Metronidazole (400 mg orally twice daily for 3 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (matched placebo orally twice daily for 3 days)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Metronidazole (10-500 microM in vitro)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (in vitro)
Number of subjects: 10
Study: 10166598

Group type: EXPERIMENTAL
Intervention: RCTs identified in nursing journals
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Systematic reviews of effectiveness
Number of subjects: 522

Group type: COMPARATOR
Intervention: Sensitivity of Medline searches
Number of subjects: 522
Study: 8314160

Group type: EXPERIMENTAL
Intervention: Epidoxorubicin, 30 mg/m2 (P-E)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Idarubicin, 6 mg/m2 (P-I)
Number of subjects: 243
Study: 3717931

Group type: EXPERIMENTAL
Intervention: Moxalactam
Number of subjects: 109

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 109

Group type: COMPARATOR
Intervention: Cefoxitin with tobramycin
Number of subjects: 109
Study: 29661523

Group type: EXPERIMENTAL
Intervention: Positive-Psychological intervention (PI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-condition
Number of subjects: 0
Study: 26921360

Group type: EXPERIMENTAL
Intervention: Gemtuzumab ozogamicin 3 mg/m2
Number of subjects: 788

Group type: COMPARATOR
Intervention: Gemtuzumab ozogamicin 6 mg/m2
Number of subjects: 788
Study: 24372521

Group type: EXPERIMENTAL
Intervention: Yamamoto new scalp acupuncture (YNSA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional Chinese acupuncture (TCA)
Number of subjects: 80
Study: 22203366

Group type: EXPERIMENTAL
Intervention: 100 mg of GABA
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo (dextrin)
Number of subjects: 63
Study: 20185343

Group type: EXPERIMENTAL
Intervention: Intra-articular sodium hyaluronate (SH) injections (5 injections at weekly intervals)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiologic saline solution injections (5 injections at weekly intervals)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Visual analog pain score reduction
Number of subjects: 40
Study: 18005508

Group type: EXPERIMENTAL
Intervention: Gender‐ and culture‐specific behavioural interventions and interactive STI counselling
Number of subjects: 853

Group type: COMPARATOR
Intervention: Control group (non-abused women)
Number of subjects: 853

Group type: EXPERIMENTAL
Intervention: Abused adolescents (<19 years)
Number of subjects: 853

Group type: EXPERIMENTAL
Intervention: Abused adults
Number of subjects: 853
Study: 15696451

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0
Study: 12083600

Group type: EXPERIMENTAL
Intervention: Behavior Management Techniques (BMTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trazodone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 10606280

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide, estramustine, or no therapy for 2 years (in NPCP 900/1000 trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estramustine with vinblastine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Flutamide
Number of subjects: 0
Study: 8567833

Group type: EXPERIMENTAL
Intervention: Analysis of basal body temperature graphs by experienced clinicians using uniform criteria
Number of subjects: 160
Study: 1514337

Group type: EXPERIMENTAL
Intervention: Propofol infusion
Number of subjects: 50
Study: 6337742

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (40 mg orally every 6 hours for 12 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (40 mg orally)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (chronic therapy)
Number of subjects: 30
Study: 30928678

Group type: EXPERIMENTAL
Intervention: DHEAS
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Cortisol
Number of subjects: 73
Study: 30968632

Group type: EXPERIMENTAL
Intervention: Probiotic (Lactobacillus Rhamnosus GG)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Saline solution (Control)
Number of subjects: 150
Study: 24444414

Group type: EXPERIMENTAL
Intervention: Continuous therapy (omeprazole 20 mg od)
Number of subjects: 117

Group type: COMPARATOR
Intervention: On-demand therapy (omeprazole 20 mg on-demand)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Continuous therapy (omeprazole 20 mg od) in NERD
Number of subjects: 117

Group type: COMPARATOR
Intervention: On-demand therapy (omeprazole 20 mg on-demand) in NERD
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Continuous therapy (omeprazole 20 mg od) in RE
Number of subjects: 117

Group type: COMPARATOR
Intervention: On-demand therapy (omeprazole 20 mg on-demand) in RE
Number of subjects: 117
Study: 22943930

Group type: EXPERIMENTAL
Intervention: DDB plus garlic oil (GO) - 2 capsules per day
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: DDB plus garlic oil (GO) - 3 capsules per day
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: DDB plus garlic oil (GO) - 6 capsules per day
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: DDB plus garlic oil (GO) - all doses
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 19445819

Group type: EXPERIMENTAL
Intervention: Low-Na base-producing (LNAB) DASH-type diet including six serves lean red meat/week
Number of subjects: 95

Group type: COMPARATOR
Intervention: High-carbohydrate low-fat (HCLF) diet with a higher acid load
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 95
Study: 17304454

Group type: EXPERIMENTAL
Intervention: Superficial cultures
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Differential quantitative blood cultures
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Differential time to positivity
Number of subjects: 204